Asthma and Respiratory Foundation NZ
Menu
Donate
Asthma and Respiratory Foundation NZ
In this section
Filter by topic:
All Asthma COPD Research Bronchiectasis Lung cancer Obstructive sleep apnoea Housing Smoking Management plans Other conditions Access to primary care Health literacy Poverty Health workforce Social determinants IPF Vaping COVID-19

The use of rongoā in contemporary physiotherapy: An exploratory study.:

Gray, K.

5 May, 2012

Rongoā is a modality for healing that incorporates plants and their derivatives to promote wellness. This traditional method of healing was used to treat a range of conditions in pre-colonisation time.

New Zealand evidence for the impact of primary healthcare investment in Capital and Coast District Health Board:

Tann, L., Carr, J.,& Reidy, J.

30 March, 2012

This paper provides New Zealand evidence on the effectiveness of primary care investment, measured through the Capital and Coast District Health Board's (DHB) Primary Health Care Framework. The Framework was developed in 2002/2003 to guide funding decisions at a DHB level, and to provide a transparent basis for evaluation of the implementation of the Primary Health Care Strategy in this district.

Improving health and energy efficiency through community-based housing interventions:

Howden-Chapman, P., Crane, J., Chapman, R., & Fougere, G.

20 August, 2011

Houses designed for one climate and cultural group may not be appropriate for other places and people. Our aim is to find cost-effective ways to improve the characteristics of older homes, ill-fitted for New Zealand's climate, in order to improve the occupants' health.

Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma:

Perrin, K. et al

19 May, 2011

Conclusion: High concentration oxygen therapy causes a clinically significant increase in PtCO2 in patients presenting with severe exacerbations of asthma. A titrated oxygen regime is recommended in the treatment of severe asthma, in which oxygen is administered only to patients with hypoxaemia, in a dose that relieves hypoxaemia without causing hyperoxaemia

Ethnic disparities in CPAP adherence in New Zealand: Effects of socioeconomic status, health literacy and self-efficacy:

Bakker, J., O’Keeffe, K., Neill, A., & Campbell, A.

30 April, 2011

This study investigated the influence of ethnicity on adherence with continuous positive airway pressure (CPAP) in a sample of 126 New Zealand patients. The authors concluded that disparity in CPAP adherence demonstrated between Māori and non-Māori can be explained in part by lower education levels and socioeconomic status.

Government response to the report of the Māori Affairs Committee on its inquiry into the tobacco industry in Aotearoa and the consequences of tobacco use for Māori (final response):

New Zealand Parliament.

1 February, 2011

The Government welcomes the Report of the Māori Affairs Committee on its Inquiry into the tobacco industry in Aotearoa and the consequences of tobacco use for Māori.

Reduced acute hospitalisation with the Healthy Housing Programme:

Jackson, G., Thornley, S., Woolston, J., Papa, D., Bernacchi, A., & Moore, T.

30 January, 2011

This study investigated the impact of the Healthy Housing Programme in reducing acute hospitalisations in South Auckland, New Zealand.

Towards better assessment and treatment of exercise induced wheeze:

Taylor, R.

12 December, 2010

In a randomized cross-over trial, cromoglycate, formoterol and montelukast were equally effective in low FENO patients.

Inquiry into the tobacco industry in Aotearoa and the consequences of tobacco use for Māori:

NZ House of Representatives Māori Affairs Committee.

11 November, 2010

With smoking rates amongst Māori double that of the general population, tobacco has a particularly devastating impact on Māori, and accounts for a significant portion of the life expectancy differential between Māori and non-Māori.

Societal costs of obstructive sleep apnoea syndrome.:

Gander, P., Scott, G., Mihaere, K., & Scott, H.

27 August, 2010

Aim: To estimate the societal costs of obstructive sleep apnoea syndrome (OSAS) in New Zealand and develop a simulation tool to evaluate treatment options.